Company: AIP
Filing Date: 2025-12-11
Form Type: S-3
Source: 0001193125-25-316098
Chunk: 10

Company: Arteris, Inc.
Filing Date: 2025-12-11
Form: S-3
Chunk 10
---
. There are no redemption or sinking fund provisions applicable to our common stock. The rights, preferences and privileges of the holders of our common stock are subject to and may be adversely affected by the rights of the holders of shares of any series of our preferred stock that we may designate in the future. Fully Paid and Nonassessable All of our outstanding shares of common stock are fully paid and nonassessable. 7

Preferred Stock

Our board of directors has the authority, without further action by our stockholders, to issue up to 10,000,000 shares of preferred stock in
one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences,
sinking fund terms and the number of shares constituting, or the designation of, such series, any or all of which may be greater than the rights of our common stock. The issuance of our preferred stock could adversely affect the voting power of
holders of our common stock and the likelihood that such holders will receive dividend payments and payments upon our liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change in
control or other corporate action. As of September 30, 2025, no shares of preferred stock are outstanding, and we have no present plan to issue any shares of preferred stock.

Options

As of September 30, 2025,
we had outstanding options to purchase 1,818,539 shares of our common stock, with a per share weighted-average exercise price of $3.33, under our 2021 Incentive Award Plan (the 2021 Plan).

Restricted Stock Units

As of
September 30, 2025, there were 4,760,502 shares of our common stock issuable upon vesting of outstanding restricted stock units.

Registration Rights

Under our investors’ rights agreement, based on the number of shares outstanding as of September 30, 2025, the
holders of approximately 9.9 million shares of our common stock, or their transferees, have the right to require us to register their shares under the Securities Act of 1933, as amended (the Securities Act) so that those shares may be publicly
resold, and the holders of approximately 9.9 million shares of our common stock, or their transferees, have the right to include their shares in